Joaquín Rodrigo has been in charge of Biosim since its creation and has just renewed as president of the biosimilars association. We reviewed with him the challenges facing the sector and the future of a market in full development.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
